Clinical trial • Phase I • Gastroenterology
LIV001 for Ulcerative colitis
Phase I trial of LIV001 for Ulcerative colitis. Randomised, placebo (dose and schedule not specified)-controlled. 8 participants.
Overview
- Trial Therapeutic Area
- Gastroenterology
- Trial Disease
- Ulcerative colitis
- Trial Stage
- Phase I
Key dates
- Initial CTIS Submission Date
- 23-07-2024
- First CTIS Authorization Date
- 18-11-2024
Trial design
Randomised, placebo (dose and schedule not specified)-controlled Phase I trial across 3 sites in Poland.
- Randomised
- Yes
- Comparator
- Placebo (dose and schedule not specified)
- Target Sample Size
- 8
- Trial Duration For Participant
- 336
Recruitment
- Planned Sample Size
- 8
- Recruitment Window Months
- 11
Geography
- Total Number Of Sites
- 3
- Total Number Of Participants
- 8
Poland
- Earliest CTIS Part Ii Submission Date
- 25-10-2024
- Latest Decision Or Authorization Date
- 02-03-2025
- Processing Time Days
- 128
- Number Of Sites
- 3
- Number Of Participants
- 8
Sites
- Site Name
- Provita Poliklinika Sp. z o.o.
- Department Name
- Gastroenterology
- Principal Investigator Name
- Marek Bugajski
- Principal Investigator Email
- marek.bugajski@gmail.com
- Contact Person Name
- Marek Bugajski
- Contact Person Email
- marek.bugajski@gmail.com
- Site Name
- Centrum Medyczne Medyk Sp. z o.o.
- Department Name
- Gastroenterology
- Principal Investigator Name
- Rafał Filip
- Principal Investigator Email
- r.filip.medyk@gmail.com
- Contact Person Name
- Rafał Filip
- Contact Person Email
- r.filip.medyk@gmail.com
- Site Name
- Centrum Badan Klinicznych Piotr Napora Lekarze sp.p.
- Department Name
- Gastroenterology
- Principal Investigator Name
- Piotr Napora
- Principal Investigator Email
- napora.piotr@cbk.wroc.pl
- Contact Person Name
- Piotr Napora
- Contact Person Email
- napora.piotr@cbk.wroc.pl
Sponsor
Primary sponsor
- Full Name
- Liveome Inc.
- Organisation Type
- Pharmaceutical company
- Country Of Registered Address
- Korea, Republic of
Investigational products
- Investigational Product Name
- LIV001
Related trials
Other published trials that may interest you.